Status:

COMPLETED

Early Child Development and Nutrition in Guatemala

Lead Sponsor:

University of Maryland, Baltimore

Collaborating Sponsors:

Association for the Study and Prevention of HIV/AIDS

Conditions:

Undernutrition

Eligibility:

All Genders

6-4 years

Phase:

NA

Brief Summary

Over 200 million children under the age of 5 years in low and middle-income countries do not reach their developmental potential, largely due to lack of adequate nutrients and lack of psychosocial sti...

Detailed Description

The plan is to implement a clustered randomized placebo controlled trial with an infant phase (6-12 months of age) and a preschool phase (36-48 months of age). For the infant phase, the investigators ...

Eligibility Criteria

Inclusion

  • Child speaks Spanish.
  • Child is age 6-12 months or age 36-48 months.
  • Child must be undernourished (length and height for age \< -1 z-score).
  • Child does not have any obvious health or developmental problems that would interfere with growth, nutrition, or development.
  • Child will remain in the area for the subsequent year.
  • Parent or legal guardian of the child is age 18 years or older.
  • Parent or legal guardian speaks and understands Spanish.
  • Parent or legal guardian lives with child in study community.

Exclusion

  • Child is not age 6-12 months or 36-48 months.
  • Child has severe stunting (length and height for age \< -3 z-scores).
  • Child has identified conditions that could interfere with their development and growth.
  • Child is severely anemic (hemoglobin \< 7).

Key Trial Info

Start Date :

February 16 2015

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 8 2015

Estimated Enrollment :

1730 Patients enrolled

Trial Details

Trial ID

NCT02302729

Start Date

February 16 2015

End Date

December 8 2015

Last Update

August 16 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

APEVIHS (Association for the Prevention and Study of HIV/AIDS)

Retalhuleu, Guatemala